The two factors that most influence how osteoarthritis (OA) of the knee is managed are the presence of other health conditions and involvement of other joint sites. As such, for the first time, OARSI has developed guidelines for the non-surgical treatment of osteoarthritis of the knee that are stratified to each of four patient groups: patients with knee-only OA and no comorbidities, patients with knee-only OA with comorbidities, patients with multi-joint OA and no comorbidities, and patients with multi-joint OA with comorbidities. Comorbities included diabetes, hypertension, cardiovascu
You are here
For the first time, OARSI has developed treatment guidelines tailored to different types of patients with osteoarthritis (OA) of the knee. These guidelines are based on a comprehensive review of the current scientific evidence for each treatment’s safety and effectiveness. Surgical treatments, the costs of treatments, or their coverage by insurance were not taken into consideration here. These guidelines are designed to help you and your physician determine the best course of treatment for your particular set of circumstances
Objective: To update evidence for available therapies in the treatment of hip and knee osteoarthritis (OA) and to examine whether research evidence has changed from 31 January 2006 to 31 January 2009.
Purpose: To develop concise, patient-focussed, up to date, evidence-based, expert consensus recommendations for the management of hip and knee osteoarthritis (OA), which are adaptable and designed to assist physicians and allied health care professionals in general and specialist practise throughout the world.
By Multiple Authors